Japanese Riken And Toppan Conduct Trials Using DNA To Select AIDS Drugs
This article was originally published in PharmAsia News
Executive Summary
Japanese Rikakaku Institute and printing company Toppan June 22 initiated a clinical trial in Thailand to forecast efficacy and adverse effects of AIDS drugs based on patient DNA types. The trial will use gene analysis device developed by Toppan subsidiary Rikan Genesis. The two companies aim to confirm the effectiveness of the device through the trials and market the product in Thailand where many AIDS patents are suffering adverse effects of AIDS drugs. (Click here for more - Japanese language
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.